Literature DB >> 4587001

Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis.

J E Edwards, R Y Foos, J Z Montgomerie, L B Guze.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4587001     DOI： 10.1097/00005792-197401000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  59 in total

1.  Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.

Authors:  P Phillips; S Shafran; G Garber; C Rotstein; F Smaill; I Fong; I Salit; M Miller; K Williams; J M Conly; J Singer; S Ioannou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

2.  Systemic candidiasis in babies with retinopathy of prematurity.

Authors:  I Kremer; N Naor; S Davidson; M Arbizo; I Nissenkorn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  Candida endophthalmitis: clinical presentation, treatment and outcome in 23 patients.

Authors:  S Schmid; A C Martenet; O Oelz
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

5.  Efficacy and Pharmacokinetics of Fosmanogepix (APX001) in the Treatment of Candida Endophthalmitis and Hematogenous Meningoencephalitis in Nonneutropenic Rabbits.

Authors:  Ruta Petraitiene; Vidmantas Petraitis; Bo Bo Win Maung; Robert S Mansbach; Michael R Hodges; Malcolm A Finkelman; Karen Joy Shaw; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

6.  Experimental Candida albicans endocarditis: characterization of the disease and response to therapy.

Authors:  M A Sande; C R Bowman; R A Calderone
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

7.  Experimental hematogenous Candida endophthalmitis: diagnostic approaches.

Authors:  D K Henderson; J E Edwards; K Ishida; L B Guze
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Experimental intraabdominal candidiasis in rabbits: therapy with low-total-dose intravenous amphotericin B.

Authors:  A S Bayer; J E Edwards; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

9.  Fluconazole in Candida albicans sepsis during pregnancy: case report and review of the literature.

Authors:  E C Wiesinger; S Mayerhofer; C Wenisch; S Breyer; W Graninger
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

10.  The Pathophysiology and Treatment of Candida Sepsis.

Authors:  Brad Spellberg; John E. Edwards
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.